Evista to prevent breast cancer
May 2006
More women will be taking Evista to prevent breast cancer.
New evidence shows that Evista (raloxifene) really does work as well as tamoxifen to reduce the risk of invasive breast cancer in postmenopausal women...and it's better tolerated.
Both drugs cut the risk of invasive breast cancer in half.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive